Market Trends of Middle East & Africa Ovarian Cancer Diagnostics And Therapeutics Industry
CT Scan Segment is Expected to Show Better Growth in the Forecast Period.
Computed Tomography (CT) is an imaging procedure that uses special X-ray equipment to create detailed pictures, or scans, of areas inside the body. It is also called computerized tomography and computerized axial tomography (CAT). This equipment does not show small ovarian tumors well, but they can see larger tumors and may be able to see if the tumor is growing into nearby structures. It can also find enlarged lymph nodes, signs of cancer spreading to the liver or other organs, or signs that an ovarian tumor is affecting the kidneys or bladder. Furthermore, the rising burden of ovarian cancer and technological advancements are expected to fuel market growth over the forecast period.
The high number of ovarian cancers in MENA countries is expected to contribute to the studied segment's growth. For instance, an article published by the Egyptian Journal of Medical Human Genetics in August 2022 reported that the incidence of ovarian cancer is expected to rise steadily by 260% of its present reported cases. Upper Egypt (6.1%) had the highest incidence, 6.1%. Lower rates were found in middle and lower Egypt (3.8% and 3.9%, respectively). Thus, the high incidence of ovarian cancer is expected to increase the demand for CT scans for its diagnosis, thereby driving the studied segment's growth.
Further, the new product developments are expected to drive the growth of the studied segment. For instance, in February 2023, GE HealthCare launched the Smart CT solution in the UAE. This is designed to help healthcare systems care for more patients with greater efficiency and enhanced clarity with up to 50% increased patient throughput, up to 30% enhanced image quality, and 85% faster daily prep thanks to improved efficiencies with higher workflow speed.
Thus, the high incidence of ovarian cancer and new product launches are expected to drive the segment's growth over the forecast period.
South Africa is Expected to Witness High Growth Over the Forecast Period.
The increasing prevalence of ovarian cancer cases among the South African population is expected to play a vital role in the growth of the studied market in South Africa. For instance, the article published in Springer Journal in March 2022 mentioned that the most prevalent cancer in Egypt was ovarian cancer (3.4%) among all cancers. Such a high prevalence of ovarian cancer among the African population is expected to contribute to the growing demand for MRI owing to the effective diagnosis, thereby fueling segment growth.
Moreover, establishing various diagnostic facilities in the country is also expected to drive the market in the country. For instance, in October 2021, Integrated Diagnostics Holdings launched Al-Borg Scan’s third branch in Egypt. The branch is equipped with the latest state-of-the-art radiology available on the market and offers a full suite of radiology services. Thus, such technological advancements are providing better diagnostic options to the people in the country, thereby driving the market.
Thus, due to the factors above, such as the high incidence of chronic diseases, the rising geriatric population, and frequent developments in the country, it is expected to witness significant growth, which can drive the studied market over the forecast period.
Middle East & Africa Ovarian Cancer Diagnostics And Therapeutics Market Report Snapshots
- Middle East & Africa Ovarian Cancer Diagnostics And Therapeutics Market Size
- Middle East & Africa Ovarian Cancer Diagnostics And Therapeutics Market Share
- Middle East & Africa Ovarian Cancer Diagnostics And Therapeutics Market Trends
- Middle East & Africa Ovarian Cancer Diagnostics And Therapeutics Companies
